RE:RE:Lot of negative articlesTomorrow will certainly be a big day for us, but some of it may come down to timing.
Relistor is expected to be approved and should give us a good shot in the arm, but the FDA meeting to discuss brodalumab, which is also on Tuesday, will likely lean towards the more negative side of things.
So a big question is, what time will the results be released on each of these tomorrow and how will the market react?